Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 48,432 shares at $47.40 ($2.3M) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Open-market sale of $2.3M TARS by President/CEO and Board Chair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 7,131 | $330K | 14.2% |
| 2 | $46.29 | 7,131 | $330K | 14.2% |
| 3 | $47.40 | 8,551 | $405K | 17.4% |
| 4 | $47.40 | 8,551 | $405K | 17.4% |
| 5 | $50.11 | 8,534 | $428K | 18.4% |
| 6 | $50.11 | 8,534 |
| $428K |
| 18.4% |
| Total | $48.03 avg | 48,432 | $2.3M | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |